<DOC>
	<DOCNO>NCT01708252</DOCNO>
	<brief_summary>Up 10 subject enrol . All subject receive increase density UltherapyTM treatment dual depth . Treatments provide low 2/3 face neck . Follow-up visit occur 90 180 day post-treatment . Study image obtain pre-treatment , 30-60 min post-treatment , follow-up visit .</brief_summary>
	<brief_title>Feasibility Study : Treatment Post-surgery Surgery Naive Patients Who Failed Respond Previous Ulthera Treatment</brief_title>
	<detailed_description>This prospective , single-site , non-randomized clinical trial efficacy additional Ultherapy™ treatment subject minimal non-responders Day 90 previous Ulthera clinical trial . Global Aesthetic Improvement Scale score patient satisfaction questionnaire obtain .</detailed_description>
	<mesh_term>Cutis Laxa</mesh_term>
	<criteria>Male female , age 30 65 year . Subject good health . BMI &lt; 30 . Skin laxity submental area demonstrate grade II III Knize scale classification cosmetic deformity cervicomental angle Previous participation ULT107 , adequate compliance treatment followup visit . Groups ( surgery surgery naïve ) designate base group assign ULT107 ) . Have concomitant surgical skin tightening procedure since Ultherapy™ treatment ULT107 . Pregnant , lactating , plan become pregnant , and/or use reliable form birth control . Presence active systemic local skin disease may affect wound healing . Severe solar elastosis . Excessive subcutaneous fat cheek . Excessive skin laxity lower face neck Significant scar area treat . Open wound lesion area treat . Severe cystic acne area treat</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Ulthera® System</keyword>
	<keyword>Ultherapy™ Treatment</keyword>
	<keyword>Ulthera , Inc .</keyword>
	<keyword>Ultrasound treatment skin tightening</keyword>
</DOC>